80441-87-8Relevant articles and documents
DEUTERATED CFTR POTENTIATORS
-
Paragraph 0150; 0152-0154, (2020/04/18)
The present invention relates to a compound of chemical formula I and pharmaceutically acceptable salts thereof. The present invention also provides a composition comprising the compound in the present invention and the use of the composition in a method for treatment of diseases and conditions which are beneficially treated by administering a CFTR potentiator.
Deuterated CFTR squalene
-
Paragraph 0153; 0156; 0157, (2018/12/02)
The invention relates to a compound shown in a formula I and pharmaceutically acceptable salts thereof. The invention further provides a composition comprising the compound and use of the composition in a treatment method of beneficially treating diseases and symptoms by using a CFTR (Cystic Fibrosis Transmembrane Regulator) synergist.
Steric Effect of Carboxylate Ligands on Pd-Catalyzed Intramolecular C(sp2)–H and C(sp3)–H Arylation Reactions
Tanji, Yutaka,Mitsutake, Naoya,Fujihara, Tetsuaki,Tsuji, Yasushi
supporting information, p. 10314 - 10317 (2018/08/06)
A bulky carboxylic acid bearing three cyclohexylmethyl substituents at the α-position, namely, tri(cyclohexylmethyl)acetic acid, is demonstrated to act as an efficient ligand source in Pd-catalyzed intramolecular C(sp2)?H and C(sp3)?H arylation reactions. The reactions proceed smoothly under mild reaction conditions, even at room temperature due to the steric bulk of the carboxylate ligands, which accelerates the rate-determining C?H bond activation step in the catalytic cycle.